Update: Bayer to pay up to €10 billion to settle bulk of Roundup weedkiller cancer lawsuits

The ruling, which permanently bars California from requiring a cancer warning on glyphosate-based products, is separate from wider litigation over whether Roundup causes a type of blood cancer.
Update: Bayer to pay up to €10 billion to settle bulk of Roundup weedkiller cancer lawsuits

California’s Office of Environmental Health Hazard Assessment had listed glyphosate in July 2017 as a chemical known to the state to cause cancer, but Bayer’s Monsanto unit (which owns the product) aggressively fought California’s move.
California’s Office of Environmental Health Hazard Assessment had listed glyphosate in July 2017 as a chemical known to the state to cause cancer, but Bayer’s Monsanto unit (which owns the product) aggressively fought California’s move.

Bayer, after more than a year of talks, agreed to pay as much as €9.8 billion to settle thousands of U.S. lawsuits claiming that its widely-used weed killer Roundup caused cancer, resolving litigation that has pummeled the company’s share price.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Farming

Newsletter

Stay ahead of the season. Sign up for insights, expert advice and stories shaping Irish agriculture.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited